Timing of Parathyroidectomy Does Not Influence Renal Function After Kidney Transplantation.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
pubmed:
25
2
2019
medline:
26
11
2019
entrez:
25
2
2019
Statut:
ppublish
Résumé
Parathyroidectomy (PTx) is the treatment of choice for end-stage renal disease (ESRD) patients with therapy-resistant hyperparathyroidism (HPT). The optimal timing of PTx for ESRD-related HPT-before or after kidney transplantation (KTx)-is subject of debate. Patients with ESRD-related HPT who underwent both PTx and KTx between 1994 and 2015 were included in a multicenter retrospective study in four university hospitals. Two groups were formed according to treatment sequence: PTx before KTx (PTxKTx) and PTx after KTx (KTxPTx). Primary endpoint was renal function (eGFR, CKD-EPI) between both groups at several time points post-transplantation. Correlation between the timing of PTx and KTx and the course of eGFR was assessed using generalized estimating equations (GEE). The PTxKTx group consisted of 102 (55.1%) and the KTxPTx group of 83 (44.9%) patients. Recipient age, donor type, PTx type, and pre-KTx PTH levels were significantly different between groups. At 5 years after transplantation, eGFR was similar in the PTxKTx group (eGFR 44.5 ± 4.0 ml/min/1.73 m In this multicenter cohort study, timing of PTx before or after KTx does not independently impact graft function over time.
Sections du résumé
BACKGROUND
Parathyroidectomy (PTx) is the treatment of choice for end-stage renal disease (ESRD) patients with therapy-resistant hyperparathyroidism (HPT). The optimal timing of PTx for ESRD-related HPT-before or after kidney transplantation (KTx)-is subject of debate.
METHODS
Patients with ESRD-related HPT who underwent both PTx and KTx between 1994 and 2015 were included in a multicenter retrospective study in four university hospitals. Two groups were formed according to treatment sequence: PTx before KTx (PTxKTx) and PTx after KTx (KTxPTx). Primary endpoint was renal function (eGFR, CKD-EPI) between both groups at several time points post-transplantation. Correlation between the timing of PTx and KTx and the course of eGFR was assessed using generalized estimating equations (GEE).
RESULTS
The PTxKTx group consisted of 102 (55.1%) and the KTxPTx group of 83 (44.9%) patients. Recipient age, donor type, PTx type, and pre-KTx PTH levels were significantly different between groups. At 5 years after transplantation, eGFR was similar in the PTxKTx group (eGFR 44.5 ± 4.0 ml/min/1.73 m
CONCLUSIONS
In this multicenter cohort study, timing of PTx before or after KTx does not independently impact graft function over time.
Identifiants
pubmed: 30798418
doi: 10.1007/s00268-019-04952-w
pii: 10.1007/s00268-019-04952-w
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1972-1980Commentaires et corrections
Type : CommentIn
Références
Levin A, Bakris GL, Molitch M et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31–38
doi: 10.1038/sj.ki.5002009
pubmed: 17091124
Tentori F, Wang M, Bieber BA et al (2015) Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 10:98–109
doi: 10.2215/CJN.12941213
pubmed: 25516917
Pihlstrom H, Dahle DO, Mjoen G et al (2015) Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation 99:351–359
doi: 10.1097/TP.0000000000000583
pubmed: 25594550
Kidney Disease: Improving Global Outcomes (KDIGO) CKD–MBD Work Group KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD–MBD). Kidney Int 2017:7
Chen J, Zhou QY, Wang JD (2015) Comparison between subtotal parathyroidectomy and total parathyroidectomy with autotransplantation for secondary hyperparathyroidism in patients with chronic renal failure: a meta-analysis. Horm Metab Res 47:643–651
doi: 10.1055/s-0035-1554689
pubmed: 26134532
Komaba H, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Fukagawa M (2015) Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 88:350–359
doi: 10.1038/ki.2015.72
pubmed: 25786097
Lou I, Foley D, Odorico SK et al (2015) How well does renal transplantation cure hyperparathyroidism? Ann Surg 262:653–659
doi: 10.1097/SLA.0000000000001431
pubmed: 26366545
De Boer IH, Gorodetskaya I, Young B, Hsu CY (2002) Chertow GMThe severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol 13:2762–2769
doi: 10.1097/01.ASN.0000034202.91413.EB
pubmed: 12397047
Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y (2004) Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 19:1281–1287
doi: 10.1093/ndt/gfh128
pubmed: 14993493
Lewin E, Garfia B, Recio FL, Rodriguez M, Olgaard K (2002) Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation. J Am Soc Nephrol 13:2110–2116
doi: 10.1097/01.ASN.0000024439.38838.03
pubmed: 12138143
Cozzolino M, Brancaccio D, Gallieni M, Galassi A, Slatopolsky E, Dusso A (2005) Pathogenesis of parathyroid hyperplasia in renal failure. J Nephrol 18:5–8
pubmed: 15772917
Lorenz K, Bartsch DK, Sancho JJ, Guigard S, Triponez F (2015) Surgical management of secondary hyperparathyroidism in chronic kidney disease-a consensus report of the European Society of Endocrine Surgeons. Langenbecks Arch Surg. 400:907–927
doi: 10.1007/s00423-015-1344-5
pubmed: 26429790
Bleskestad IH, Bergrem H, Leivestad T, Goransson LG (2011) Intact parathyroid hormone levels in renal transplant patients with normal transplant function. Clin Transplant 25:E566–E570
doi: 10.1111/j.1399-0012.2011.01515.x
pubmed: 21955131
Lou I, Schneider DF, Leverson G, Foley D, Sippel R, Chen H (2016) Parathyroidectomy is underused in patients with tertiary hyperparathyroidism after renal transplantation. Surgery 159:172–180
doi: 10.1016/j.surg.2015.08.039
pubmed: 26603850
van der Plas WY, Engelsman AF, Ozyilmaz A et al (2017) Impact of the introduction of calcimimetics on timing of parathyroidectomy in secondary and tertiary hyperparathyroidism. Ann Surg Oncol 24(1):15–22. https://doi.org/10.1245/s10434-016-5450-6
doi: 10.1245/s10434-016-5450-6
pubmed: 27459979
Parikh S, Nagaraja H, Agarwal A et al (2013) Impact of post-kidney transplant parathyroidectomy on allograft function. Clin Transplant 27:397–402
doi: 10.1111/ctr.12099
pubmed: 23448282
pmcid: 3932484
Callender GG, Malinowski J, Javid M et al (2017) Parathyroidectomy prior to kidney transplant decreases graft failure. Surgery 161:44–50
doi: 10.1016/j.surg.2016.10.003
pubmed: 27863776
Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y (2005) Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transplant 20:1714–1720
doi: 10.1093/ndt/gfh892
pubmed: 15919696
Schwarz A, Rustien G, Merkel S, Radermacher J, Haller H (2007) HDecreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant 22:584–591
doi: 10.1093/ndt/gfl583
pubmed: 17035377
Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
doi: 10.7326/0003-4819-150-9-200905050-00006
pubmed: 19414839
pmcid: 2763564
Jeon HJ, Kim YJ, Kwon HY et al (2012) Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int 25:1248–1256
doi: 10.1111/j.1432-2277.2012.01564.x
pubmed: 23020185
Littbarski SA, Kaltenborn A, Gwiasda J et al (2018) Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy. Surgery 163:373–380
doi: 10.1016/j.surg.2017.10.016
pubmed: 29284591
Baia LC, Heilberg IP, Navis G, de Borst MH (2015) NIGRAM investigatorsPhosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol 11:656–666
doi: 10.1038/nrneph.2015.153
pubmed: 26416497
Legendre C, Canaud G, Martinez F (2014) Factors influencing long-term outcome after kidney transplantation. Transpl Int 27:19–27
doi: 10.1111/tri.12217
pubmed: 24138291
Pitt SC, Sippel RS, Chen H (2009) Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am 89:1227–1239
doi: 10.1016/j.suc.2009.06.011
pubmed: 19836494
pmcid: 2905047
van Ballegooijen AJ, Reinders I, Visser M, Brouwer IA (2013) Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies. Am Heart J 165(655–64):664.e1–664.e5